Spyre Therapeutics
SYRE
#4706
Rank
S$2.18 B
Marketcap
$37.30
Share price
2.59%
Change (1 day)
167.50%
Change (1 year)

Spyre Therapeutics (SYRE) Fails to deliver data

Key failure to deliver metrics for Spyre Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spyre Therapeutics (SYRE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Spyre Therapeutics (SYRE) - since 2023

Volume in USD (price x number of shares), data since 2023

Spyre Therapeutics (SYRE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$43.61 M407.92%
2023S$8.58 M